Watch FDA's public review of Ampligen for ME/CFS, online Dec 20   (8 votes) ProHealth.com • December 7, 2012 Tweet previous article next article Midnight Dec 6 was the deadline for patient submission of comments to be considered in the FDA's Dec 20 public review of Ampligen for potential approval as an Rx treatment for ME/CFS. Now, patients & advocates are invited to view the live webcast of this public review on Dec 20, 8 am to 5 pm Eastern time. Oral testimony is scheduled for approximately 1 pm to 2:30 pm Eastern time. The FDA has indicated it will post details, including the web address for the webcast and background material for the meeting, sometime on Dec 18 at this FDA site: http://www.fda.gov/AdvisoryCommittees/Calendar/ucm324972.htm. The FDA also plans to post the webcast in its archive for later viewing.

previous article   Rating 5 (8 votes) next article Tweet

RELATED PRODUCT CATEGORIES

ProHealth offers a wide range of nutritional supplements for optimal health.* *These products are not intended to diagnose, treat, cure, or prevent any disease. Energy Supplements Immune Support ME/CFS Support

DISCUSS THIS ARTICLE   (1 existing comment)

Testinonies for FDA meeting
Posted by: pokeydna Dec 8, 2012	Was this review helpful?     43
Patients wanting to send in their comments or testimony can send it to me Bob Miller At 511bobmiller42@gmail.com and I will present it along with my testimony at the FDA meeting on December 20th. As always we appreciate the support from ProHealth to the ME/CFS community. Thank you Rick Carson, Bob Miller
Reply